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The European war has brought about a greatly increaseddemand 
for  antimeningococcic serum.  Epidemic meningitis is known to  be 
one of the attendants of armies in barracks and in the field, and the 
present war has proven no exception to this rule.  Information is at 
hand indicating that at  least  the principal, if not all  the belligerent 
countries have suffered from epidemics of meningitis to a  greater or 
less extent.  Now that we have knowledge of the manner in which 
epidemic meningitis is conveyed, namely, by means of meningococcus 
carriers who harbor that microorganism in the nasopharynx, the ap- 
pearance of meningitis in widely separated countries and places is not 
at all remarkable.  Meningococcic meningitis has prevailed either in 
epidemic form  or  sporadically in  many European  countries during 
the past 10 or more years.  Hence the bringing together of recruits 
has  had  the effect of introducing carriers  of  the infection into  the 
midst of t.he European armies.  Not until the European war is over 
and the medical data  of the war have been collected and analyzed 
shall  we know whether  the epidemics have  been of  equal  severity 
throughout or whether some have been of greater severity than others. 
But the interim observations and  studies  have already yielded  cer- 
tain definite information of great importance in respect to the com- 
bating of  the  disease through the employment of  the specific anti- 
meningococcus serum. 
Types of Meningococeus. 
Biological  studies  of  meningococci have  led  to  their  separation 
into  two main groups,  called  respectively meningococci, or  normal 
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meningococci,  1  and  parameningococci  (Dopter2).  The  two  main 
groups are distinguished not by their cultural properties, but by their 
immunity  reactions.  This  divergence  in  immunity  reaction  has 
proven  of the  greatest  importance  in  perfecting  the  antimeningitis 
serum, since its action is specific and it affects those types of meningo- 
cocci only for which its antibodies possess affinity. 
At the outset, and before the two main groups of meningococci were 
clearly differentiated, the antimeningitis serum was prepared by em- 
ploying a number of strains of meningococci in the immunizing proc- 
ess.  The  object, of  course,  was to cover ordinary variation in im- 
munity properties  of the different cultures;  but  with  the  discovery 
of the two types of meningococci this haphazard  method no  longer 
sufficed and it became necessary to use for purposes of immunization 
representatives of the two groups now designated meningococci and 
parameningococci.  The sera now being  prepared  are  for  the most 
part  produced by immunizing horses  either with  mixtures  of  these 
types of meningococci or with alternate injections of the two types. 
Our recent studies indicate, however, that it does not suffice merely 
to  employ  representative  normal  and  representative  parameningo- 
coccus strains  for the purpose  of  immunization,  for while  the  two 
groups  are,  immunologically  considered,  fairly  homogeneous,  yet 
within each group there exist organisms which  react  weakly  to  the 
specific immune bodies produced by other strains  of the same type. 
On the other hand, when these weakly reacting strains are themselves 
inoculated  they evoke  the  formation  of  specific immune bodies  to 
which they react strongly.  Hence it is desirable to employ for immu- 
nization  not merely one,  but  rather  several strains  of each  group; 
and it is further desirable to change or alternate the strains as new 
ones are obtained which show an imperfect response to the immunity 
bodies already present. 
The  existence of different types  of meningococcus was  indicated 
early in the course of the serum treatment of meningitis through the 
observation that in certain cases the meningococci when brought un- 
der the influence of the antiserum failed to be affected by it.  Since 
this was the exception, it was assumed that certain strains of meningo- 
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cocci were resistant,  or  fast,  to  the antimeningitis  serum.  Further 
studies,  as has been mentioned, established the fact that  two great 
groups of meningococci could be distinguished; and our later studies 
indicated that even within these groups variants occur which are less 
subject  to  the  action of a  polyvalent antimeningitis serum than the 
majority of strains. 
We are at present only imperfectly informed as to the relative preva- 
lence of the different types of meningococci in given foci of epidemic 
meningitis.  The  American experiences and  apparently  the  experi- 
ences previous to recent studies in the war zone in France and England 
have  indicated  that  normal  meningococci greatly  preponderate  in 
cases of epidemic meningitis.  It now appears that, in certain locali- 
ties at least in which epidemic meningitis prevails in France and Eng- 
land  among  the army,  the  proportion  of  cases caused by  normal 
meningococci as  contrasted with cases  caused  by parameningococci 
may be no higher than 6  : 4  (Ellis,  3 ArkwrighO). 
This  consideration has definite bearing on the preparation of anti- 
meningitis  serum  and  emphasizes  the  importance  of proceeding in 
its preparation in such a manner as to produce quantitative results in 
which the antibodies for the parameningococci about equal in amount 
those for the normal strains. 
Mode  of Preparation  of the Serum. 
At the first appearance of the present outbreak of epidemic menin- 
gitis  in  Great Britain,  The  Rockefeller Institute was  no  longer en- 
gaged in  the preparation  of the antimeningifis serum.  Two circum- 
stances led to the resumption of its manufacture  The first was the 
probability that the epidemics abroad would extend and the demand 
for the serum would exceed that available from ordinary sources of 
supply.  Moreover,  the  identification  of  The  Rockefeller Institute 
with the original production of the serum brought to it urgent requests 
for serum from several of the countries at war, with which it seemed 
imperative  to  comply.  Through  the  assistance  rendered  by  The 
Rockefeller Foundation, which has been engaged extensively in war 
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relief, funds were placed at the disposal of the Institute covering the 
cost of production of the serum,  so that  it  could  be supplied  gratis 
to those countries from which the demand came. 
But there was a  second important  reason which led to the resump- 
tion of the manufacture of the serum.  At the time and after the ap- 
pearance  of  epidemic  meningitis,  particularly  among  the  British 
recruits,  the  supply of serum  available in England  was  chiefly that 
prepared commercially.  Its use was distinctly disappointing.  Real- 
izing that in all probability the failure lay with the samples of serum 
available,  which by reason of some fault of  production  or preserva- 
tion were inactive, it seemed desirable to produce a serum the activity 
of which could be relied upon  (Osler, Rolleston~). 
In a previous communication s from the laboratories of the Institute 
a  method  was described by means  of which  the  preparation  of  the 
antidysenteric  serum  was  greatly  abbreviated.  The  method  con- 
sists  in  making  injections  into  the  horse  of  cultures  or  extracts  of 
dysentery bacilli on 3 successive days, after which a  period of rest is 
permitted.  It  was ascertained  that  the  immunity  response  to  the 
bacteria or bacterial products thus injected was far greater than when 
they were introduced  at  periods  separated  from  each  other  by  the 
ordinary  intervals  of  time.  Moreover,  it  was  determined  that  by 
this  rapid method an efficient polyvalent anfidysenteric serum  could 
be  produced,  representing  both  the  non-acid  (Shiga)  and  the  acid 
(Flexner)  groups  of  bacilli.  Instead  of  a  period of  8  or  12  months 
required  by  the  usual  method  of  immunization,  an  equally strong 
serum was produced in the short period of 8 or 12 weeks. 
The problem presented,  therefore,  in respect to the antimeningitis 
serum seemed essentially similar  to that encountered with respect to 
the antidysenteric serum.  In  the  case of  the  latter,  two  groups  of 
the bacilli are dealt with:  first, a fixed or Shiga group, which  yields a 
soluble toxin; and second, a fluctuating group made up of very slightly 
divergent  types of bacilli which do not yield a  soluble toxin.  In the 
case of the meningococci there are also two groups  or types, neither 
being perhaps  altogether fixed:  the ordinary or normal meningococci 
Discussion  on  the  treatment  of  cerebrospinal  meningitis,  _Proc. Roy.  Soc. 
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which  readily undergo  autolysis,  and  the  parameningococci under- 
going less perfect autolysis, both yielding, however, a  toxic product. 
Hence it  could be assumed that by employing a  method similar  to 
that worked out for the antidysenteric serum, horses might be ren- 
dered immune and made to yield an efficient polyvalent antimeningo- 
coccic serum in a  period of time far shorter than is required by the 
usual method of subcutaneous inoculation.  The substances employed 
in both instances are the same; namely, living cultures and the ex- 
tract, or autolysate, inoculated alternately.  By the old method from 
6  to  12 months were required  to produce a  meningococcic serum  of 
high immunity value.  By the new method a  similar result has been 
achieved in from 8 to 12 weeks. 
In following out this plan, a  difficulty was early encountered, and 
one which was  indeed foreseen.  Two general methods  of immuni- 
zation of horses  have been  followed for the production of antimen- 
ingitis serum.  In one the cultures of meningococci or the autolysate 
is injected subcutaneously (Flexner and JoblingT); in  the other,  the 
injections are made intravenously (DopterS).  In the first instance, 
no ill effects arise, aside from the occasional production of sterile ab- 
scesses.  In the other, after several inoculations have been made, the 
horses become extremely sensitive,  so  that  sudden  death  has been 
known to follow an injection of the culture or autolysate.  This dan- 
ger can, however, be prevented, as has been shown by Dopter, 9 by 
employing a  desensitizing injection of the culture before making the 
full inoculation. 
Hence the method adopted for the rapid production of the anti- 
meningitis serum follows closely, but does not exactly reproduce, that 
already described for the rapid production of the antidysenteric serum. 
It consists in beginning with small doses of living meningococci in- 
jected daily for 3 days, followed by a period of rest of 7 days, when 
another series of injections is made.  Thus for a  1,300pound horse, 
one-twentieth of a  24 hour culture on slanted plain agar is injected 
on the  1st day.  The material  for  injection is made up  as  follows: 
2 cc. of physiological salt solution are added to a  24 hour agar slant 
7 Flexner, S., and Jobling, J. W., your. Exper. Med.,  1908,  x,  141. 
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of meningococcus culture and the growth is suspended in it.  Then 
0.1  cc. of the suspension is transferred to  15 cc. of physiological salt 
solution and injected intravenously very slowly.  The  temperatures 
are taken hourly, beginning with the 4th hour after the injection, and 
continued until the temperature has reached its highest and begun to 
decline.  24  hours  later 0.2  cc.  of  the suspension,  and  on  the  3rd 
day 0.3 cc., that is about one-seventh of the agar slant, is used.  Af- 
ter the lapse of 7 days, the dose given on the first of the 3 days cor- 
responds with that given at the end of the last series; namely, in the 
instance  in  question, 0.3 cc.  The  temperature  is again  taken, and 
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Typical febrile rise and fall following each single injection of 
if the rise does not equal  2.5-3°C.  the conclusion drawn is  that  the 
dose has been too small.  It is increased, therefore, for  the injection 
24 hours later above the usual rate  of increase of 0.1  cc.  according 
to  the.degree of  rise of temperature.  If  the temperature does  not 
fall to normal within 18 to 24 hours, the conclusion is drawn that the 
dose given has been too large (Text-fig. 1). 
Following  this  plan,  doses  may be  regulated  with  nicety and  a 
maximum of reaction be  obtained,  we believe,  with  a  minimum of 
danger.  No  serious effect is  produced,  although  chills  may attend 
the severer reactions.  The greatest reaction, as a  rule, is  that pro- HAROLD  L.  A~OSS  AND  MAllTHA  WOLLSTEIN  409 
duced by the first injection, whereas the succeeding injections on the 
2nd and 3rd day tend to produce  less severe reactions.  Hence  the 
increase between the second  and  the  third  injection may be larger 
than that between the first and second.  In the second series of in- 
jections, the maximum doses have been from 0.4  to 0.45  cc., and in 
the third  series  from 0.5 to 0.6 cc. on the 3rd day.  Since individual 
horses vary in  their susceptibility, the first  doses are small and the 
temperature  curve  forms  the  basis  for  adjusting  the  other  doses 
(Text-fig. 2). 
In  Horse  N  only two  series  of  injections were  necessary before 
the typical  and desired  temperature curve was attained.  The suc- 
ceeding curves  for any series agree closely with  the  third  series in 
the chart. 
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Chart of Horse N showing febrile reactions and adjustment of 
three series of injections. 
In  the  succeeding series increase in  the amounts  injected  is  ac- 
complished by the addition of new strains  from time to  time.  For 
example, when the total dose is 0.6  cc. (i.e.,  slightly more  than one- 
third of the agar slant) it may consist of 0.2 cc. each of three strains. 
The largest amount of any single injection in  a  1,300  pound horse 
has been one-fourth of each slant from seventeen different strains. 
In preparing a  polyvalent serum two slightly different procedures 
may be followed.  According to one, the normal and the paramenin- 
gococcus strains  are inoculated  within  what may be  designated  as 
periods of two series; that is, the normal and the parameningococcus 
strains are alternated.  According to the other, in which the autoly- 
sale  is  also  employed, the period  includes three  series,  one for the 
normal meningococcus, one for the parameningococcus strains, and one 
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of a typical normal meningococcus and of a typical parameningococcus 
strain.  Evidence is  at  hand, to  be referred to  below,  which  shows 
that  the autolysate,  at  least  in  the sheep,  excites  little  agglutinin 
formation while producing other protective principles. 
Desensitization. 
As stated, the horse becomes hypersensitive to the intravenous in- 
jections of the meningococci or its products apparently after the third 
or fourth series of injections.  This reaction tends to be most severe 
after the first dose in each series, as might have been predicted.  It 
was found that,  acting upon the suggestion of Dopter, 9 desensitiza- 
tion may be effected apparently readily and certainly.  Hence on the 
1st day of each series about one-twentieth (later one-tenth) of  a  24 
hour slant of culture is injected intravenously, and 2 hours later  the 
remainder  of  the  dose  is  given.  This  desensitization  suffices  and 
need not be repeated on the 2nd and 3rd days, when the next doses are 
injected. 
The  danger from both  brain  and lung emboli must not be over- 
looked.  BulP  ° has observed that suspensions of bacteria, introduced 
into the blood stream of an animal immune to the same organism, are 
clumped and deposited in the blood vessels of the  brain,  lungs,  and 
in the spleen.  If the bacteria are present in any considerable  num- 
ber,  the clumps may occlude the cerebral and pulmonary capillaries 
and produce sudden death of the animal.  We have found this to be 
true in the injection of meningococcus into normal and immune rab- 
bits.  It is possible that a part of the so called anaphylactic phenom- 
ena observed in  immunization with meningococci can  be  explained 
by these facts, since the symptoms observed are similar if not identi- 
cal in these two instances. 
In order to avoid such a  possible danger the suspensions of living 
meningococci are made up to a relatively larger volume, 15 to 20 cc., 
and introduced very slowly into the circulation. 
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Strains  Employed in the Immunizing  Process. 
In the beginning a group of five representative normal meningococ- 
cus strains and a group consisting of an equal number of paramenin- 
gococcus strains were used alternately in the series of injections.  The 
progress of the formation of immune bodies in the serum was followed 
by studying the agglutination, opsonization, and complement devia- 
tion reactions, with as many strains of meningococci as possible.  In 
this manner strains not employed in the original series of inoculations 
may be divided into temporary lots according to their reaction with 
the serum.  If the reactions are not within or near the zone of reac- 
tion of the strains already being used for immunization, representa- 
tives of such lots are selected and placed in the immunizing group. 
The remaining members of these lots are again tested later when im- 
mune bodies against the representative of the group have appeared in 
the serum.  Should the serum now Contain antibodies effective against 
all members of the group, it will,  of course, not be necessary to in- 
clude them all.  Agglutination serves as  the most specific index of 
immunological reaction except in  the case of  inagglutinable strains, 
which, in our experience, are infrequently encountered. 
By  the  above  procedure  we  have  studied  sixty-four  strains  of 
meningococci, and from this number twenty-two were selected to be 
added to  the two original immunizing groups which consisted respec- 
tively of five normal meningococcus strains and five parameningococ- 
cus strains.  For convenience in regulating the doses and for injecting 
we have added equally to each group. 
We selected for addition to the normal group eleven of those which 
showed the least variation from the normal meningococcus; and the 
remaining eleven, exhibiting wider variations, were placed in the sec- 
ond  group  which  originally  consisted  only  of  parameningococci. 
The strains used at present for immunizing are thirty-two, and have 
for convenience been divided into  two lots.  Lot A  consisted origi- 
nally of five normal and irregular strains  of meningococcus, and  to 
these have been added eleven normal and  irregular strains.  Lot  B 
consisted originally of five parameningococcus strains (two from the 
Pasteur Institute, Paris, and three isolated in America) and to these 
have been added eleven parameningococcus and irregular strains  ex- 
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successive injections and after a  rest of 7 days the other lot is used 
in like manner.  If care is not taken  to balance the two lots, the im- 
mune bodies against one group may be developed to a greater extent 
than  those against  the other.  To avoid this,  the serum is tested im- 
munologically  after  every  second  series  if  living  organisms  are  in- 
jected, and  after every third  series if autolysate is also given.  The 
relative doses of the two groups are regulated accordingly. 
Since we have evidence that both  normal  meningococci and para- 
meningococci  differ among  themselves  in  antigenic  power,  it  is  de- 
sirable  to study all  possible  strains  in  the  course of an  epidemic in 
order that strains which are at variance with those being used in the 
production of an immune serum may be included in the immunizing 
groups. 
This  point  is  illustrated  by  the  following  experience  with  two 
strains.  Strain  NO  was  tested  against  the  polyvalent  serum  of a 
horse highly immune against at least twenty normal and parameningo- 
coccus strains  and found  to  be  agglutinated  in  a  dilution  of 1 : 10. 
This strain,  which was later found to be parameningococcus,  was in- 
cluded in  the immunizing  group,  and  after  two inoculations  the  ag- 
glutinins  rose to  1 : 100,  and  after four injections  to  1 : 200.  When 
fewer strains are  being used,  the  immune  bodies  may be developed 
more  quickly.  Strain  Andrews,  brought  from  England  by Dr.  A. 
Gardner Robb, when tested against a  potent serum effective against 
ten normal  meningococcus and  parameningococcus  strains, agglutin- 
ated  in  a  dilution  of  1:10.  It  was  included  in  the  immunizing 
group  and  after  two series of  injections,  the agglutinating  power of 
the serum for this  strain rose to 1 : 200.  We consider that the larger 
doses of Andrews which it was  possible  to  employ caused  the  more 
rapid  rate  in  the production  of the  agglutinins.  Table  I  illustrates 
the  development of agglutinins  for  strains  relatively inagglutinable 
before their  inclusion  in  the inoculation group. 
TABLE  I. 
Before  After  After  After  After 
Strains.  injection.  1 injection.  2 injections.  4 injections.  5 injections. 
~ndrews...  1:10  1:100  1:200  1  : 2,000 
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Autolysate. 
Equal parts of toluene autolysate  u from normal meningococcus and 
from parameningococcus may be injected intravenously on 3 succes- 
sive days forming one series, alternating with the two series of living 
meningococci.  The  serum of horses  receiving the autolysate series 
develops agglutinins,  opsonins,  or power to deviate complement less 
quickly  than  that  of  animals  receiving  only  the  living  organisms, 
though power to neutralize the toxin contained in  the autolysate is 
developed. 
TABLE  II. 
Serum. 
;heep B 
autolysate). 
torse L 
Uving cultures 
nd autolysate)... .... 
Agglutinins. 
Normal  Paramenln- 
menlngo- 
COCCUS.  goco£eus. 
1  : 100  1  : 50 
1:5,000  1:2,0001 
Opsonins.  Complement deviation. 
Antigen 
Normal  Paramenin-  from normal 
meningo-  gococcus,  meningo-  COCCUS. 
COCCUS. 
1:50  1:1,000 1:200 
1:2,000  1:5,000 1:10,000 
Antigen 
from 
paramenin- 
gocoecuB. 
1 : 100 
1 : 5,000 
A  sheep received intravenously  maximum  doses of  autolysate in 
series of 3  successive days and a  rest of 7 days over  a  period  of 9 
months.  Doses sufficient in size to cause marked febrile reaction and 
sometimes diarrhea, were administered.  At the end of 9 months the 
serum exhibited only slight power of agglutination, opsonization, and 
complement deviation. 
Table II  shows the titer of the sheep serum compared with  that 
of serum obtained from a  horse receiving autolysate and also living 
meningococci. 
The  sheep  serum  when  incubated  with  living meningococci and 
~njected intraperitoneally into small guinea pigs was found to possess 
low anti-infectious value. 
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Immunity  Value of the Antiserum. 
The  immune  bodies  of the  horse  serum  were  estimated  by testing 
its agglutinating and opsonizing power with normal and parameningo- 
coccus strains  and by determining  its power to fix complement in the 
presence  of  antigens  made  from these  strains.  Its  anti-infectious 
power was determined  by incubating varying amounts with one mini- 
mum  lethal  dose of  living  meningococci  for 1 hour at  37°C.,  and in- 
jecting the mixture intraperitoneally  into young guinea pigs weighing 
not less than 90 or more than  110 gin. 
Agglutinatio~.--Representafive  normal  meningococci  and  parame- 
ningococci were selected for following the development of agglutinins. 
TABLE  III. 
Horse L Serum. 
Period. 
Vleningqcoc- 
¢US. 
Paramenin- 
gococcus.. 
d  .o 
*d  1st. 
l:3q  1:60 
1:10 ...... 
2nd.  4th. 
1:80 1 : 1,000 
1:80 1:200 
7th.* 
1 : 5,00£ 
1 : 2,0001 
After 6 
wks. of 
autolvs-  lOth. 
ateinjec- 
tioos.t 
1 : 2,000 1 : 2,000 
1:500  1:1,000 
llth.~  13th. 
1:500  1:I,000 
1  : 1,00C  1 : 1,000 
14th. 
1  : 2,00( 
1  : 2,0'0( 
* 7 periods extend over 10 weeks.  6 liters of blood were taken from the horse 
at this time. 
t For 6 weeks after the 9th period the horse received  autolysate only. 
:~ Twelve new strains added.  1st period after bleeding. 
Horse M  Serum. 
Before 
Period.  injection. 
Meningococcus .................  1 : 20 
Parameningococcus .............  1 : 10 
2nd. 
1 : 500 
1 : 50* 
4th. 
1:500 
1  : 1,000 
7th.  10th. 
1:1,000  1:2,00(] 
1:1,000  1:2,000 
10 periods extend over 12½ weeks. 
* This low figure shows that  the injections  had  not been properly balanced. 
Too few parameningococci had been injected; accordingly larger doses were given 
with  the result  that  the agglutinins increased greatly during the  next  periods. 
The  highest  dilution  at  which  any  of our  sera  agglutinated  was  1:5,000  for 
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The reactions  were  made  at  55°C.  and  read  after  24  hours.  Table 
III shows  the  increase  of agglutinins  by periods. 
Opsonins.--The  opsonins  were  estimated  by  the  Neufeld  tech- 
nique.  Table IV shows their development by periods. 
TABLE  IV. 
Horse L Serum. 
Period.  5th.  7th.  9th.  Interval 
of 6 wks. 
Meningococcus.  1 : 50~  1 : 1,000  1 : 500*  Injected 
with auto- 
Parameningo-  lysate 
coccus.  1 : 20(]  1 : 5,000  1 : 2,000  only. 
10th.  13th.  15th. 
1:500  1:1,000  1:2,000 
1:1,000  1:1,000  1:2,000 
* Bled 6 liters just before this period. 
Horse M  Serum. 
Period.  2rid. 
~Ieningococcus.  1 : 500 
?arameningococcus  1 : 200 
7th. 
1 : 200 
1 : 1,000 
llth. 
1 : 2,000 
1 : 2,000 
Complement  Fixation.--Tests  for  complement-binding  bodies  in 
the immune horse and  sheep  sera were made with  antigens  of regular 
normal  meningococci  as  well  as  with  those  of  irregular  normal 
meningococcus  and  parameningococcus  strains.  The  results  are 
shown  in  Table V.  It  appears  that  in  the  serum  from Horse L  the 
power  to  bind  complement  ran  fairly  parallel  with  the  power  to 
agglutinate  the  meningococci. 
TABLE  V. 
Complement Deviation by Serum L. 
Period. 
Meningo- 
COCCUS  .  .  . 
Paramenin- 
gococcus. 
4th. 
I : 200 
1:100 
7th.  8th. 
1 : 1,000 1 : 1,00C 
1 : 500  I : 1,0013 
9th. 
1 : 2,000 
1 : 2,000 
Interval 
of 6wks. 
Injected 
with auto- 
lysate 
only. 
lOth. 
1 : 1,000 
1 : 500 
llth. 
1: 50C 
1:500 
12th.  13th. 
1  1,000 1 : 1,000 
1:500  1:2,000 
|14th. 
1 : 1,000 
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Complement Deviation by Serum M. 
Period. 
~Ienkngococcus 
l?arameningococcus.  . . 
2nd. 
1 : 200 
1 : 200 
4th.  5th. 
1:2,000  1:5,000 
1:1,000  1:2,000 
6tb. 
1 : 2,000 
1  : 1,000 
9th.  12th. 
1:2,000  1:1,000 
1:1,000  1:5,00o 
Protective  Value.--Flexner  recommended  the  use  of  small  guinea 
pigs in determining the anti-infectious power of antimeningitis serum. 
If young guinea pigs weighing between 90 and  110 gin.  are used and 
the experiment is  run in  quadruplicate, some measure of the protec- 
tive power is obtained.  One minimum lethal dose of the living men- 
ingococcus is incubated with varying  amounts  of  immune serum for 
1 hour at 37°C. and then injected intraperitoneally. 
Table  VI  shows  the  anti-infectious  power  of  serum  L  compared 
with normal  horse  serum. 
TABLE  VI. 
Anti-Infectious  Power of Polyvalent Antimeningitis  Serum. 
2 cc. of  0.2 cc. of  0.3 ce. of  0.4 cc. of 
Strain.  normal horse  po]yvalent immune  polyvalent immune  polyva]ent immune 
serum,  serum,  serum,  serum, 
m. l. d. of living  No protection.  Protection in 1  Protection in 3  Protection in 4. 
meningococci,  out of 4.  out of 4. 
m. 1. d. of living  No protection.  Protection in 3  Protection in 3  Protection in 4. 
parameningo-  out of 4.  out of 4. 
cocci. 
If two minimum lethal doses are used, there is little protection after 
48 hours.  For example, in one series the control guinea pig receiving 
one  minimum  lethal  dose  and  those  receiving two  minimum  lethal 
doses plus 0.5 cc. of serum died in 12 to 18 hours.  Three out of four 
guinea pigs  receiving two minimum lethal doses plus 0.6 cc. of serum 
lived between 47  and 48 hours. 
Normal  horse  serum  exerts  practically  no  anti-infectious  action 
either  with  meningococcus  or  with  parameningococcus.  Immune 
serum  produced by the  rapid method possesses a  considerable degree HAROLD  L.  AMOSS  AND  MARTHA  WOLLSTEIN  417 
of anti-infectious power.  About 0.4 cc.  of this polyvalent serum is 
capable  of neutralizing the infecting power of one minimum lethal 
dose of the living meningococcus or parameningococcus. 
SUMMARY. 
Potent antimeningitis serum can be  safely produced in  the horse 
by the method of three successive intravenous inoculations of living 
meningococci and parameningococci repeated at stated intervals. 
Sudden and alarming symptoms and sudden death are avoided by 
employing first a  desensitizing injection and  then by  adjusting the 
doses according to the febrile reaction and by making the highly di- 
luted injections slowly. 
Horses undergoing this process of immunization remain in good con- 
dition and may even gain in weight. 
Specific immune bodies appear in the serum early and rise rapidly. 
By  inoculating alternately several  strains  of living meningococci 
and parameningococci, and  the autolyzed products of each, a  poly- 
valent serum of high fiter can be produced in 8  to  12 weeks instead 
of in the 10 months required by the subcutaneous method. 
The serum produced by this rapid method has been employed thera- 
peutically in America, England, France, and some other countries. 
It is highly desirable  to isolate meningococci from many sources 
and test the strains against the polyvalent serum.  Strains which are 
not agglutinated in high dilution in such a serum should be included 
subsequently in the lot of strains used for immunization. 